Results 1 to 10 of about 8,980 (210)

Incidence and outcomes of postoperative paralytic ileus after cytoreductive surgery with HIPEC: A population-based study. [PDF]

Colorectal Dis
Abstract Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is standard treatment for peritoneal metastases in Sweden. Prolonged postoperative ileus (PPOI) is a common complication following major abdominal surgery and is associated with increased morbidity and prolonged hospitalization.
Ghanipour L, Mahmmud LO, Huang B, Palmer GJ, Cashin P, Abraham-Nordling M.   +5 more
europepmc   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer: Distinguishing Prophylactic and Therapeutic Roles Within Contemporary Multimodal Management. [PDF]

Cureus
Dayis S, Alshaikh M, Alosaimi R, Almutairi S, Jamjoom E, Alotaibi T, Al-Hajeili M, Bazarbashi S, Aseafan M.   +8 more
europepmc   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a single-institution experience. [PDF]

Radiol Oncol
Pilko G, Petric R.
europepmc   +1 more source

Patient-Derived Organoid Models and Precision HIPEC in Diffuse Malignant Peritoneal Mesothelioma: Modeling Heterogeneity to Address Recurrence. [PDF]

Int J Mol Sci
Makris EA, Ives JK, Votanopoulos K.
europepmc   +1 more source

Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases. [PDF]

Ann Surg Oncol
Oppat KM, Bennett FJ, Patel SH, Raoof M, Baumgartner JM, Mogal HD, Lambert LA, Abbott DE, Greer JB, Grotz TE, Fournier KF, Dineen SP, Powers B, Zaidi MY, Winer JH, Russell MC, Staley CA, Cloyd JM, Maithel SK, Concors SJ.   +19 more
europepmc   +1 more source

Postoperative electrolyte disturbances: Overlooked risk factors for prolonged postoperative ileus after cytoreductive surgery with HIPEC. [PDF]

Colorectal Dis
Qian Y.
europepmc   +1 more source

Tailoring HIPEC with Patient-Derived Organoids in Colorectal Peritoneal Metastases: Results from the First Stage of the Prospective Phase II OrganoHIPEC Clinical Trial (Clinicaltrials.gov NCT06057298). [PDF]

Cancers (Basel)
Baratti D, Varinelli L, Guaglio M, Kusamura S, Cavalleri T, Battistessa D, Sabella G, Colletti G, Gariboldi M, Deraco M.   +9 more
europepmc   +1 more source

Interval debulking with HIPEC in patient with VP shunt. [PDF]

Gynecol Oncol Rep
Shanoada R, Stephens J, Al-Wahab ZR.
europepmc   +1 more source

Current Approaches and Emerging Strategies in the Treatment of Peritoneal Carcinomatosis. [PDF]

Int J Mol Sci
Alyasova A, Efendiev K, Reshetov I, Ilyasova D, Shpileva O, Loschenov V, Makarov V, Zakharova E, Karalkin P, Agakina Y, Gilyadova A, Cheremisov V, Stetsiuk A, Nebezhev A, Kozlova P, Ataeva A, Rostislavova E, Sudarkina V, Shiryaev A.   +18 more
europepmc   +1 more source

Impact of <i>KRAS</i> Mutation on Recurrence-Free Survival in Colon Cancer Patients Undergoing Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy in a Predominantly Hispanic Population. [PDF]

Cancers (Basel)
Hernandez AE, Borowsky PA, Cash CJ, Montealegre M, Gomez KP, Noe D, Yadegarynia S, Pimentel A, Bahna H, Möller MG.   +9 more
europepmc   +1 more source